Biology of Blood and Marrow Transplantation
Volume 9, Issue 11 , Pages 674-682 , November 2003

Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia

  • Alessandra Takatu

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    • ,
  • Richard A Nash

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    • University of Washington, Seattle, Washington, USA
    • ,
  • Jan M Zaucha

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    • ,
  • Marie-Terese Little

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    • ,
  • George E Georges

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    • University of Washington, Seattle, Washington, USA
    • ,
  • George E Sale

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    • University of Washington, Seattle, Washington, USA
    • ,
  • Eustacia Zellmer

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    • ,
  • Christian S Kuhr

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    • University of Washington, Seattle, Washington, USA
    • ,
  • Clinton D Lothrop Jr

      Affiliations

    • Scott-Ritchey Research Center, Auburn University, Auburn, Alabama, USA
    • ,
  • Rainer Storb

      Affiliations

    • Corresponding Author InformationCorrespondence and reprint requests: Rainer Storb, MD, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., D1-100, P.O. Box 19024, Seattle, WA 98109-1024, USA
    • Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    • University of Washington, Seattle, Washington, USA

Received 20 June 2003 ,Accepted 14 August 2003.

References 

  1. Searcy GP, Tasker JB, Miller DR. Animal model of human disease (pyruvate kinase deficiency). Am J Pathol. 1979;94:689–692
  2. Prasse KW, Crouser D, Beutler E, Walker M, Schall WD. Pyruvate kinase deficiency anemia with terminal myelofibrosis and osteosclerosis in a beagle. J Am Vet Med Assoc. 1975;166:1170–1175
  3. Weiden PL, Hackman RC, Deeg HJ, Graham TC, Thomas ED, Storb R. Long-term survival and reversal of iron overload after marrow transplantation in dogs with congenital hemolytic anemia. Blood. 1981;57:66–70
  4. Weiden PL, Storb R, Graham TC, Schroeder ML. Severe hereditary haemolytic anaemia in dogs treated by marrow transplantation. Br J Haematol. 1976;33:357–362
  5. Thomas ED, Buckner CD, Sanders JE, et al.  Marrow transplantation for thalassaemia. Lancet. 1982;2:227–229
  6. Walters MC. Hematopoietic cell transplantation for sickle cell disease. In:  Thomas ED,  Blume KG,  Forman SJ editor. Hematopoietic Cell Transplantation. Second Edition. Boston: Blackwell Science; 1999;p. 1145–1153
  7. Lucarelli G, Clift RA. Marrow transplantation in thalassemia. In:  Thomas ED,  Blume KG,  Forman SJ editor. Hematopoietic Cell Transplantation. Second Edition. Boston: Blackwell Science; 1999;p. 1137–1144
  8. Zaucha JM, Yu C, Lothrop CD, et al.  Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation. Biol Blood Marrow Transplant. 2001;7:14–24
  9. Georges GE, Storb R, Thompson JD, et al.  Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation. Blood. 2000;95:3262–3269
  10. Whitney KM, Goodman SA, Bailey EM, Lothrop CD. The molecular basis of canine pyruvate kinase deficiency. Exp Hematol. 1994;22:866–874
  11. Whitney KM, Lothrop CD. Genetic test for pyruvate kinase deficiency of Basenjis. J Am Vet Med Assoc. 1995;207:918–921
  12. Wagner JL, Burnett RC, DeRose SA, Francisco LV, Storb R, Ostrander EA. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation. 1996;62:876–877
  13. Wagner JL, Burnett RC, Works JD, Storb R. Molecular analysis of DLA-DRBB1 polymorphism. Tissue Antigens. 1996;48:554–561
  14. Storb R, Yu C, Wagner JL, et al.  Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood. 1997;89:3048–3054
  15. Yunusov MY, Georges GE, Storb R, et al.  FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease. Transplantation. 2003;75:933–940
  16. Yu C, Ostrander E, Bryant E, Burnett R, Storb R. Use of (CA)n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation. 1994;58:701–706
  17. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow (I. Normal erythroid development). Blood. 1987;69:255–263
  18. Strasser SI, Kowdley KV, Sale GE, McDonald GB. Iron overload in bone marrow transplant recipients. Bone Marrow Transplant. 1998;22:167–173
  19. Dekmezian R, Kantarjian HM, Keating MJ, Talpaz M, McCredie KB, Freireich EJ. The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia. Cancer. 1987;59:1739–1743
  20. Tanphaichitr VS, Suvatte V, Issaragrisil S, et al.  Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency. Bone Marrow Transplant. 2000;26:689–690
  21. Walters MC, Patience M, Leisenring W, et al.  Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 2001;7:665–673
  22. Kapelushnik J, Or R, Filon D, et al.  Analysis of β-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation. Blood. 1995;86:3241–3246
  23. Black JA, Rittenberg MB, Standerfer RJ, Peterson JS. Hereditary persistence of fetal erythrocyte pyruvate kinase in the Basenji dog. In:  Brewer GJ editors. The Red Cell. New York: Alan R. Liss; 1978;p. 275–290
  24. Morimoto M, Kanno H, Asai H, et al.  Pyruvate kinase deficiency of mice associated with nonspherocytic hemolytic anemia and cure of the anemia by marrow transplantation without host irradiation. Blood. 1995;86:4323–4330
  25. Wagemaker G, Visser TP, van Bekkum DW. Cure of murine thalassemia by bone marrow transplantation without eradication of endogenous stem cells. Transplantation. 1986;42:248–251
  26. van den Bos C, Kieboom D, Wagemaker G. Correction of murine beta-thalassemia by partial bone marrow chimerism (selective advantage of normal erythropoiesis). Bone Marrow Transplant. 1993;12:9–13
  27. Kean LS, Durham MM, Adams AB, et al.  A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation. Blood. 2002;99:1840–1849
  28. Iannone R, Luznik L, Engstrom LW, et al.  Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia. Blood. 2001;97:3960–3965
  29. Andreani M, Manna M, Lucarelli G, et al.  Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood. 1996;87:3494–3499
  30. Kapelushnik J, Or R, Aker M, et al.  Allogeneic cell therapy of severe beta thalassemia major by displacement of host stem cells in mixed chimera by donor blood lymphocytes. Bone Marrow Transplant. 1997;19(suppl 2):96–98
  31. Collins RH, Shpilberg O, Drobyski WR, et al.  Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol. 1997;15:433–444
  32. Kolb HJ, Schattenberg A, Goldman JM, et al.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood. 1995;86:2041–2050
  33. Kolb HJ, Gunther W, Schumm M, Holler E, Wilmanns W, Thierfelder S. Adoptive immunotherapy in canine chimeras. Transplantation. 1997;63:430–436
  34. Mackinnon S, Papadopoulos EB, Carabasi MH, et al.  Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation (separation of graft-versus-leukemia responses from graft-versus-host disease). Blood. 1995;86:1261–1268
  35. Bonini C, Ferrari G, Verzeletti S, et al.  HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 1997;276:1719–1724

PII: S1083-8791(03)00293-3

doi: 10.1016/j.bbmt.2003.08.005

Biology of Blood and Marrow Transplantation
Volume 9, Issue 11 , Pages 674-682 , November 2003

Article Tools

* Image Usage & Resolution